A Mab A Case Study In Bioprocess Development Portable -

By using Design of Experiments (DoE), developers gain a deeper understanding of how process parameters interact.

: Minapharm Pharmaceuticals successfully implemented a two-step purification strategy for a mAb biosimilar. By using a mixed-mode resin (Nuvia aPrime 4A) in the polishing step, they eliminated an entire chromatography step. This approach significantly reduced production costs, process time, buffer consumption, and media costs , while increasing overall product yield .

and bioreactor pH levels, the team shifted the metabolic profile of the CHO (Chinese Hamster Ovary) cells, reducing initial impurity formation. Downstream Innovation: A Mab A Case Study In Bioprocess Development

, specifically aggregates and fragments, which threatened the stability and efficacy of the final therapeutic. The Solution: A Quality by Design (QbD) Approach Instead of traditional trial-and-error, the team utilized a QbD framework to identify Critical Quality Attributes (CQAs): Upstream Optimization: By fine-tuning the feed strategy

A two-stage depth filtration system was selected. The primary coarse filter captured whole cells and large fragments, while the secondary fine filter trapped sub-micron colloidal particles and nucleic acids. By using Design of Experiments (DoE), developers gain

As the demand for mAbs continues to grow, the development of efficient and cost-effective bioprocesses will remain a critical aspect of biotechnology. The A Mab case study serves as a model for bioprocess development, highlighting the importance of collaboration, process optimization, and regulatory compliance.

Coarse depth filter to capture whole cells and large debris. The Solution: A Quality by Design (QbD) Approach

The downstream process must purify mAb-101 from host cell impurities while maintaining high recovery yields. A standard three-column platform process was optimized for this molecule. Harvest and Clarification

Defines the clinical goals, including safety, efficacy, and dosage. Critical Quality Attributes (CQAs):